 | • レポートコード：MRC2-11QY13649 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はアルコール性肝炎治療のグローバル市場について調査・分析したレポートです。種類別（モノクローナル抗体、カスパーゼプロテアーゼ阻害剤、コルチコステロイド、血液レオロジー剤、アナボリックステロイド、肝向性ホルモン、スルフヒドリル剤、その他）市場規模、用途別（病院・診療所、研究開発）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別アルコール性肝炎治療の競争状況、市場シェア ・世界のアルコール性肝炎治療市場：種類別市場規模 2015年-2020年（モノクローナル抗体、カスパーゼプロテアーゼ阻害剤、コルチコステロイド、血液レオロジー剤、アナボリックステロイド、肝向性ホルモン、スルフヒドリル剤、その他） ・世界のアルコール性肝炎治療市場：種類別市場規模予測 2021年-2026年（モノクローナル抗体、カスパーゼプロテアーゼ阻害剤、コルチコステロイド、血液レオロジー剤、アナボリックステロイド、肝向性ホルモン、スルフヒドリル剤、その他） ・世界のアルコール性肝炎治療市場：用途別市場規模 2015年-2020年（病院・診療所、研究開発） ・世界のアルコール性肝炎治療市場：用途別市場規模予測 2021年-2026年（病院・診療所、研究開発） ・北米のアルコール性肝炎治療市場分析：米国、カナダ ・ヨーロッパのアルコール性肝炎治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのアルコール性肝炎治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のアルコール性肝炎治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのアルコール性肝炎治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Alkermes、Conatus pharmaceuticals、Dainippon sumitomo pharma、Generon corporation、Immuron limited、Lupin Laboratories、Intercept Pharmaceuticals、Teva Pharmaceuticals、Sanofi-Aventis ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Alcoholic hepatitis is a kind of liver disease usually affects people who are used to be heavy drinkers. It can cause short and long-term liver damage. Liver is a major organ of body functions to remove poisons such as alcohol from blood. It’s damaged by long time heavy drinking of alcohol. Usually occur in 30% of long- time alcohol drinkers. Asymptomatic steatohepatitis is also as alcoholic hepatitis the term is used to describe the acute onset of symptomatic hepatitis. Symptoms include changes I appetite, dry mouth, yellowing of skin or eyes, weight loss, fever and fatigue. Sometime alcoholic hepatitis could get serious conditions include fluid buildup in the abdomen, confusion or brain fog and bleeding in esophagus or stomach. Treatment for alcoholic hepatitis involves therapies and drinking cessation to ease the sign and symptoms of liver damage. Corticosteroids are the current main treatment for alcoholic hepatitis in patients who do not have contraindication for steroid treatment. Corticosteroids are the medications have shown short-term benefits in increasing survival of certain people suffer with alcoholic hepatitis. Pentoxifylline is recommend to patients who can’t take corticosteroids. Studies indicate that pentoxifylline might not be effective for people with mild alcoholic hepatitis or people who have not respond to steroid treatment.
The global alcoholic hepatitis therapeutics market is expected to witness a favorable growth during the forecast period. Increasing incidence of liver diseases and high success rate of pipeline drugs are the major factors which increase global alcoholic hepatitis market. Moreover high adoption rate for novel therapeutic products and increasing prevalence of alcoholic liver disease are some other factors that are expected to fuel the demand of global alcoholic hepatitis market. Global alcoholic hepatitis market shows potential to be expanding and lucrative field due to increasing merger and acquisitions among pharmaceutical companies to develop advance therapies for treating liver diseases. Furthermore, increased focus on retaining best quality of life is one the factor contributing to the growth of the market. However increasing health care expenditure, stringent reimbursement policies and high development cost are some factors that might hinder the growth of alcoholic hepatitis therapeutics market in forecast period.
Market Analysis and Insights: Global Alcoholic Hepatitis Therapeutic Market
The global Alcoholic Hepatitis Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Alcoholic Hepatitis Therapeutic Scope and Market Size
Alcoholic Hepatitis Therapeutic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alcoholic Hepatitis Therapeutic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Alkermes
Conatus pharmaceuticals
Dainippon sumitomo pharma
Generon corporation
Immuron limited
Lupin Laboratories
Intercept Pharmaceuticals
Teva Pharmaceuticals
Sanofi-Aventis
Market segment by Type, the product can be split into
Monoclonal Antibodies
Caspase Protease Inhibitor
Corticosteroids
Hemorheologic Agents
Anabolic Steroids
Hepatotropic Hormones
Sulfhydryl Agents
Others
Market segment by Application, split into
Hospitals and Clinics
Research and Development
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Alcoholic Hepatitis Therapeutic Revenue
1.4 Market by Type
1.4.1 Global Alcoholic Hepatitis Therapeutic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monoclonal Antibodies
1.4.3 Caspase Protease Inhibitor
1.4.4 Corticosteroids
1.4.5 Hemorheologic Agents
1.4.6 Anabolic Steroids
1.4.7 Hepatotropic Hormones
1.4.8 Sulfhydryl Agents
1.4.9 Others
1.5 Market by Application
1.5.1 Global Alcoholic Hepatitis Therapeutic Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Clinics
1.5.3 Research and Development
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Alcoholic Hepatitis Therapeutic Market Perspective (2015-2026)
2.2 Global Alcoholic Hepatitis Therapeutic Growth Trends by Regions
2.2.1 Alcoholic Hepatitis Therapeutic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Alcoholic Hepatitis Therapeutic Historic Market Share by Regions (2015-2020)
2.2.3 Alcoholic Hepatitis Therapeutic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Alcoholic Hepatitis Therapeutic Market Growth Strategy
2.3.6 Primary Interviews with Key Alcoholic Hepatitis Therapeutic Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Alcoholic Hepatitis Therapeutic Players by Market Size
3.1.1 Global Top Alcoholic Hepatitis Therapeutic Players by Revenue (2015-2020)
3.1.2 Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Players (2015-2020)
3.1.3 Global Alcoholic Hepatitis Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Alcoholic Hepatitis Therapeutic Market Concentration Ratio
3.2.1 Global Alcoholic Hepatitis Therapeutic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Alcoholic Hepatitis Therapeutic Revenue in 2019
3.3 Alcoholic Hepatitis Therapeutic Key Players Head office and Area Served
3.4 Key Players Alcoholic Hepatitis Therapeutic Product Solution and Service
3.5 Date of Enter into Alcoholic Hepatitis Therapeutic Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Alcoholic Hepatitis Therapeutic Historic Market Size by Type (2015-2020)
4.2 Global Alcoholic Hepatitis Therapeutic Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020)
5.2 Global Alcoholic Hepatitis Therapeutic Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Alcoholic Hepatitis Therapeutic Market Size (2015-2020)
6.2 Alcoholic Hepatitis Therapeutic Key Players in North America (2019-2020)
6.3 North America Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020)
6.4 North America Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020)
7 Europe
7.1 Europe Alcoholic Hepatitis Therapeutic Market Size (2015-2020)
7.2 Alcoholic Hepatitis Therapeutic Key Players in Europe (2019-2020)
7.3 Europe Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020)
7.4 Europe Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020)
8 China
8.1 China Alcoholic Hepatitis Therapeutic Market Size (2015-2020)
8.2 Alcoholic Hepatitis Therapeutic Key Players in China (2019-2020)
8.3 China Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020)
8.4 China Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020)
9 Japan
9.1 Japan Alcoholic Hepatitis Therapeutic Market Size (2015-2020)
9.2 Alcoholic Hepatitis Therapeutic Key Players in Japan (2019-2020)
9.3 Japan Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020)
9.4 Japan Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Alcoholic Hepatitis Therapeutic Market Size (2015-2020)
10.2 Alcoholic Hepatitis Therapeutic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020)
10.4 Southeast Asia Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020)
11 India
11.1 India Alcoholic Hepatitis Therapeutic Market Size (2015-2020)
11.2 Alcoholic Hepatitis Therapeutic Key Players in India (2019-2020)
11.3 India Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020)
11.4 India Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Alcoholic Hepatitis Therapeutic Market Size (2015-2020)
12.2 Alcoholic Hepatitis Therapeutic Key Players in Central & South America (2019-2020)
12.3 Central & South America Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020)
12.4 Central & South America Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Alkermes
13.1.1 Alkermes Company Details
13.1.2 Alkermes Business Overview
13.1.3 Alkermes Alcoholic Hepatitis Therapeutic Introduction
13.1.4 Alkermes Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020))
13.1.5 Alkermes Recent Development
13.2 Conatus pharmaceuticals
13.2.1 Conatus pharmaceuticals Company Details
13.2.2 Conatus pharmaceuticals Business Overview
13.2.3 Conatus pharmaceuticals Alcoholic Hepatitis Therapeutic Introduction
13.2.4 Conatus pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020)
13.2.5 Conatus pharmaceuticals Recent Development
13.3 Dainippon sumitomo pharma
13.3.1 Dainippon sumitomo pharma Company Details
13.3.2 Dainippon sumitomo pharma Business Overview
13.3.3 Dainippon sumitomo pharma Alcoholic Hepatitis Therapeutic Introduction
13.3.4 Dainippon sumitomo pharma Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020)
13.3.5 Dainippon sumitomo pharma Recent Development
13.4 Generon corporation
13.4.1 Generon corporation Company Details
13.4.2 Generon corporation Business Overview
13.4.3 Generon corporation Alcoholic Hepatitis Therapeutic Introduction
13.4.4 Generon corporation Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020)
13.4.5 Generon corporation Recent Development
13.5 Immuron limited
13.5.1 Immuron limited Company Details
13.5.2 Immuron limited Business Overview
13.5.3 Immuron limited Alcoholic Hepatitis Therapeutic Introduction
13.5.4 Immuron limited Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020)
13.5.5 Immuron limited Recent Development
13.6 Lupin Laboratories
13.6.1 Lupin Laboratories Company Details
13.6.2 Lupin Laboratories Business Overview
13.6.3 Lupin Laboratories Alcoholic Hepatitis Therapeutic Introduction
13.6.4 Lupin Laboratories Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020)
13.6.5 Lupin Laboratories Recent Development
13.7 Intercept Pharmaceuticals
13.7.1 Intercept Pharmaceuticals Company Details
13.7.2 Intercept Pharmaceuticals Business Overview
13.7.3 Intercept Pharmaceuticals Alcoholic Hepatitis Therapeutic Introduction
13.7.4 Intercept Pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020)
13.7.5 Intercept Pharmaceuticals Recent Development
13.8 Teva Pharmaceuticals
13.8.1 Teva Pharmaceuticals Company Details
13.8.2 Teva Pharmaceuticals Business Overview
13.8.3 Teva Pharmaceuticals Alcoholic Hepatitis Therapeutic Introduction
13.8.4 Teva Pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020)
13.8.5 Teva Pharmaceuticals Recent Development
13.9 Sanofi-Aventis
13.9.1 Sanofi-Aventis Company Details
13.9.2 Sanofi-Aventis Business Overview
13.9.3 Sanofi-Aventis Alcoholic Hepatitis Therapeutic Introduction
13.9.4 Sanofi-Aventis Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020)
13.9.5 Sanofi-Aventis Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Alcoholic Hepatitis Therapeutic Key Market Segments
Table 2. Key Players Covered: Ranking by Alcoholic Hepatitis Therapeutic Revenue
Table 3. Ranking of Global Top Alcoholic Hepatitis Therapeutic Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Alcoholic Hepatitis Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monoclonal Antibodies
Table 6. Key Players of Caspase Protease Inhibitor
Table 7. Key Players of Corticosteroids
Table 8. Key Players of Hemorheologic Agents
Table 9. Key Players of Anabolic Steroids
Table 10. Key Players of Hepatotropic Hormones
Table 11. Key Players of Sulfhydryl Agents
Table 12. Key Players of Others
Table 13. Global Alcoholic Hepatitis Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Alcoholic Hepatitis Therapeutic Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Alcoholic Hepatitis Therapeutic Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Alcoholic Hepatitis Therapeutic Market Share by Regions (2015-2020)
Table 17. Global Alcoholic Hepatitis Therapeutic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Alcoholic Hepatitis Therapeutic Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Alcoholic Hepatitis Therapeutic Market Growth Strategy
Table 23. Main Points Interviewed from Key Alcoholic Hepatitis Therapeutic Players
Table 24. Global Alcoholic Hepatitis Therapeutic Revenue by Players (2015-2020) (Million US$)
Table 25. Global Alcoholic Hepatitis Therapeutic Market Share by Players (2015-2020)
Table 26. Global Top Alcoholic Hepatitis Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alcoholic Hepatitis Therapeutic as of 2019)
Table 27. Global Alcoholic Hepatitis Therapeutic by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Alcoholic Hepatitis Therapeutic Product Solution and Service
Table 30. Date of Enter into Alcoholic Hepatitis Therapeutic Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 33. Global Alcoholic Hepatitis Therapeutic Market Size Share by Type (2015-2020)
Table 34. Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Type (2021-2026)
Table 35. Global Alcoholic Hepatitis Therapeutic Market Size Share by Application (2015-2020)
Table 36. Global Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 37. Global Alcoholic Hepatitis Therapeutic Market Size Share by Application (2021-2026)
Table 38. North America Key Players Alcoholic Hepatitis Therapeutic Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Alcoholic Hepatitis Therapeutic Market Share (2019-2020)
Table 40. North America Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 41. North America Alcoholic Hepatitis Therapeutic Market Share by Type (2015-2020)
Table 42. North America Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 43. North America Alcoholic Hepatitis Therapeutic Market Share by Application (2015-2020)
Table 44. Europe Key Players Alcoholic Hepatitis Therapeutic Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Alcoholic Hepatitis Therapeutic Market Share (2019-2020)
Table 46. Europe Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Alcoholic Hepatitis Therapeutic Market Share by Type (2015-2020)
Table 48. Europe Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Alcoholic Hepatitis Therapeutic Market Share by Application (2015-2020)
Table 50. China Key Players Alcoholic Hepatitis Therapeutic Revenue (2019-2020) (Million US$)
Table 51. China Key Players Alcoholic Hepatitis Therapeutic Market Share (2019-2020)
Table 52. China Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 53. China Alcoholic Hepatitis Therapeutic Market Share by Type (2015-2020)
Table 54. China Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 55. China Alcoholic Hepatitis Therapeutic Market Share by Application (2015-2020)
Table 56. Japan Key Players Alcoholic Hepatitis Therapeutic Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Alcoholic Hepatitis Therapeutic Market Share (2019-2020)
Table 58. Japan Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Alcoholic Hepatitis Therapeutic Market Share by Type (2015-2020)
Table 60. Japan Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Alcoholic Hepatitis Therapeutic Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Alcoholic Hepatitis Therapeutic Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Alcoholic Hepatitis Therapeutic Market Share (2019-2020)
Table 64. Southeast Asia Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Alcoholic Hepatitis Therapeutic Market Share by Type (2015-2020)
Table 66. Southeast Asia Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Alcoholic Hepatitis Therapeutic Market Share by Application (2015-2020)
Table 68. India Key Players Alcoholic Hepatitis Therapeutic Revenue (2019-2020) (Million US$)
Table 69. India Key Players Alcoholic Hepatitis Therapeutic Market Share (2019-2020)
Table 70. India Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 71. India Alcoholic Hepatitis Therapeutic Market Share by Type (2015-2020)
Table 72. India Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 73. India Alcoholic Hepatitis Therapeutic Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Alcoholic Hepatitis Therapeutic Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Alcoholic Hepatitis Therapeutic Market Share (2019-2020)
Table 76. Central & South America Alcoholic Hepatitis Therapeutic Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Alcoholic Hepatitis Therapeutic Market Share by Type (2015-2020)
Table 78. Central & South America Alcoholic Hepatitis Therapeutic Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Alcoholic Hepatitis Therapeutic Market Share by Application (2015-2020)
Table 80. Alkermes Company Details
Table 81. Alkermes Business Overview
Table 82. Alkermes Product
Table 83. Alkermes Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020) (Million US$)
Table 84. Alkermes Recent Development
Table 85. Conatus pharmaceuticals Company Details
Table 86. Conatus pharmaceuticals Business Overview
Table 87. Conatus pharmaceuticals Product
Table 88. Conatus pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020) (Million US$)
Table 89. Conatus pharmaceuticals Recent Development
Table 90. Dainippon sumitomo pharma Company Details
Table 91. Dainippon sumitomo pharma Business Overview
Table 92. Dainippon sumitomo pharma Product
Table 93. Dainippon sumitomo pharma Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020) (Million US$)
Table 94. Dainippon sumitomo pharma Recent Development
Table 95. Generon corporation Company Details
Table 96. Generon corporation Business Overview
Table 97. Generon corporation Product
Table 98. Generon corporation Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020) (Million US$)
Table 99. Generon corporation Recent Development
Table 100. Immuron limited Company Details
Table 101. Immuron limited Business Overview
Table 102. Immuron limited Product
Table 103. Immuron limited Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020) (Million US$)
Table 104. Immuron limited Recent Development
Table 105. Lupin Laboratories Company Details
Table 106. Lupin Laboratories Business Overview
Table 107. Lupin Laboratories Product
Table 108. Lupin Laboratories Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020) (Million US$)
Table 109. Lupin Laboratories Recent Development
Table 110. Intercept Pharmaceuticals Company Details
Table 111. Intercept Pharmaceuticals Business Overview
Table 112. Intercept Pharmaceuticals Product
Table 113. Intercept Pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020) (Million US$)
Table 114. Intercept Pharmaceuticals Recent Development
Table 115. Teva Pharmaceuticals Business Overview
Table 116. Teva Pharmaceuticals Product
Table 117. Teva Pharmaceuticals Company Details
Table 118. Teva Pharmaceuticals Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020) (Million US$)
Table 119. Teva Pharmaceuticals Recent Development
Table 120. Sanofi-Aventis Company Details
Table 121. Sanofi-Aventis Business Overview
Table 122. Sanofi-Aventis Product
Table 123. Sanofi-Aventis Revenue in Alcoholic Hepatitis Therapeutic Business (2015-2020) (Million US$)
Table 124. Sanofi-Aventis Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alcoholic Hepatitis Therapeutic Market Share by Type: 2020 VS 2026
Figure 2. Monoclonal Antibodies Features
Figure 3. Caspase Protease Inhibitor Features
Figure 4. Corticosteroids Features
Figure 5. Hemorheologic Agents Features
Figure 6. Anabolic Steroids Features
Figure 7. Hepatotropic Hormones Features
Figure 8. Sulfhydryl Agents Features
Figure 9. Others Features
Figure 10. Global Alcoholic Hepatitis Therapeutic Market Share by Application: 2020 VS 2026
Figure 11. Hospitals and Clinics Case Studies
Figure 12. Research and Development Case Studies
Figure 13. Alcoholic Hepatitis Therapeutic Report Years Considered
Figure 14. Global Alcoholic Hepatitis Therapeutic Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Alcoholic Hepatitis Therapeutic Market Share by Regions: 2020 VS 2026
Figure 16. Global Alcoholic Hepatitis Therapeutic Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Alcoholic Hepatitis Therapeutic Market Share by Players in 2019
Figure 19. Global Top Alcoholic Hepatitis Therapeutic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alcoholic Hepatitis Therapeutic as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Alcoholic Hepatitis Therapeutic Revenue in 2019
Figure 21. North America Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Alcoholic Hepatitis Therapeutic Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed
B型肝炎ウイルス（HBV）の世界市場（～2026年） Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic Hepatitis B which results in severe complications, rising awareness about the consequences of viral infection, rigorous efforts to eliminate the viral infectio…- 肝炎検査診断の世界市場（～2026年） Hepatitis is generally classified into two types based on the duration for which the patient suffers. If the condition lasts for less than six months, then it is classified as acute, when the condition persists for more than six months, then it is a case of chronic condition. Hepatitis testing refer…
- 治療用組換え抗体・タンパク質の世界市場（～2026年） Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specific…
- 予防的B型肝炎ウイルスワクチンの世界市場（～2026年） The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer. The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth…
- C型肝炎治療薬の世界市場（～2026年） Hepatitis is inflammation of the liver characterized by yellowed eyes and skin due to bilirubin, flu-like symptoms which include nausea, vomiting, poor appetite, joint pain, headaches, clay colored stools etc. Hepatitis is caused by a variety of factors both microbial and non-microbial. However hepa…